Anticoccidial Drugs Market: Major Trends Reshaping the Future of the Industry

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Anticoccidial Drugs Industry Market Size Be by 2025?
In the recent past, there has been a significant upsurge in the size of the anticoccidial drugs market. The market, which stood at $1.27 billion in 2024, is forecasted to rise to $1.35 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 6.6%. Factors such as a global increase in coccidiosis incidence, a rise in pet adoption, the economic effect, a high prevalence of coccidiosis, and growing concerns about food safety and animal health have contributed to the growth observed in the historical period.

What's the Long-Term Growth Forecast for the Anticoccidial Drugs Market Size Through 2029?
The market size for anticoccidial drugs is predicted to experience robust growth in the coming years, swelling to "$1.75 billion in 2029 with a compound annual growth rate (CAGR) of 6.5%. The growth anticipated over this forecast period can be credited to an increase in veterinary healare, a higher incidence of coccidiosis in animals, a rise in the usage of synthetic medications, an uptick in the demand for feed supplements, and a boost in livestock production. Key developments occurring over the forecast period involve a rise in demand instigated by newly evolving strains of coccidiosis, a transitioning towards natural and alternative treatment approaches, heightened regulatory oversight spurring innovation, a growing consumer preference for poultry products free of antibiotics, advancements in drug administration technologies, a heightened emphasis on preventative healare initiatives, and broadening applications in the aquaculture and companion animal industries.

View the full report here:
https://www.thebusinessresearchcompany.com/report/anticoccidial-drugs-global-market-report

What Are the Key Growth Drivers Fueling the Anticoccidial Drugs Market Expansion?
The surge in the demand for protein derived from meat is predicted to boost the anticoccidial drug market's expansion. Meat proteins, which include a range of essential amino acids necessary for various bodily functions, are inherently found in animal tissues. Shifts in dietary preferences towards foods rich in protein, alongside population growth, urbanization, and rising disposable incomes, are all factors increasing the demand for these proteins. Anticoccidial medications are crucial in contemporary animal farming, as they help maintain the health and productivity of animals. This empowers farmers to answer the growing protein demand in an efficient and sustainable manner. For exemplification, in July 2023, the Organization for Economic Co-operation and Development (OECD), a France-based intergovernmental organization, and the Food and Agriculture Organization, an Italy-based specialized agency, published a report. In contrast to a forecasted 2% increase in average global meat demand per capita from the 2020-2022 base period to 2032, the FAO meat price index spiked by 10% in 2022 due to decreased export supplies. Hence, this escalating demand for meat proteins is fuelling the anticoccidial drug market's ascent.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15723&type=smp

Which Emerging Trends Are Transforming the Anticoccidial Drugs Market in 2025?
Leading firms in the anticoccidial drugs market are emphasizing the development of novel strategies, like synthetic coccidiostat, to boost effectiveness, curtail resistance expansion, and deal with new issues in poultry and livestock administration. Synthetic coccidiostat is a chemically formulated substance used to prevent or manage coccidiosis by curbing the growth and proliferation of coccidia parasites in animals. For illustration, Zoetis, an American animal healare firm, introduced Avi-Deccox in March 2023, a revamped synthetic coccidiostat intended to deter coccidiosis in broiler chickens. This product is specifically engineered to target pathogens Eimeria acervulina and Eimeria tenella, which are accountable for substantial financial setbacks in poultry farming. Decoquinate serves as the active constituent in this product, mirroring its precursor, Deccox. Avi-Deccox tackles the escalating problem of resistance associated with the regular use of ionophores in poultry farming by applying an alternate method of action, offering a more efficient short-term knock-down effect.

How Is the Anticoccidial Drugs Market Segmented?
The anticoccidial drugs market covered in this report is segmented -

1) By Drug Class: Ionophore, Antibiotic, Sulphonamides, Chemical Derivative, Other Drug Classes
2) By Drug Action: Coccidiostatic, Coccidiocidal
3) By Application: Poultry, Swine, Fish, Cattle, Companion Animals
4) By Distribution Channel: Veterinary Hospitals, Retail Pharmacy, Other Distribution Channels

Subsegments:
1) By Ionophore: Monensin, Lasalocid, Salinomycin
2) By Antibiotic: Tylosin, Lincomycin, Bacitracin
3) By Sulphonamides: Sulfadimethoxine, Sulfaquinoxaline
4) By Chemical Derivative: Diclazuril, Clopidol
5) By Other Drug Classes: Amprolium, Robenidine

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15723&type=smp

Which Companies Are Leading the Charge in Anticoccidial Drugs Market Innovation?
Major companies operating in the anticoccidial drugs market are Johnson & Johnson, Merck and Co. Inc., Bayer AG, Novartis AG, Eli Lilly and Company Ltd., Boehringer Ingelheim GmbH, Zoetis Inc., Elanco Animal Health Incorporated, Intas Pharmaceuticals Ltd., Ceva Santé Animale S.A., Virbac S.A., Phibro Animal Health Corporation, Vetoquinol SA, Alpharma BVBA, Kepro B.V., Kemin Industries Inc., Tianjin Ringpu Bio-Technology Co. Ltd., Hester Biosciences Limited, Huvepharma AD, Biovet S.A., Lallemand Animal Nutrition, HIPRA, Impextraco NV, Venkateshwara Hatcheries Pvt Ltd

Which Regions Are Leading the Global Anticoccidial Drugs Market in Revenue?
North America was the largest region in the anticoccidial drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anticoccidial drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15723

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email:saumyas@tbrc.info
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.